TEVA.N - | Stock Price & Latest News | Reuters
Teva may pay as much as $3.6 billion in opioid settlement | Business Insurance
Teva, Allergan Ready To Pay $5B To Settle Lawsuits Related To Opioid Painkillers: Bloomberg
CVS Picks Migraine Drugs by Teva, Eli Lilly, Snubs Amgen, Reuters Reports | Ctech
Teva, Viatris win U.S. appeal in patent fight over Parkinson's drug | Reuters
Israeli unions warn Teva Pharm over plan to close Ashdod plant
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva Pharmaceutical | PBS NewsHour
US court invalidates key TEVA drug patent
Teva in talks to buy Allergan big generic-drug unit: WSJ | Reuters.com
Teva Pharmaceutical Industries' new CEO Jeremy Levin speaks during a news conference in Tel Aviv May 9, 2012. Teva Pharmaceutical Industries posted a 40 percent jump in quarterly profit that beat estimates,
Shlomo Yanai, Teva's president and chief executive, speaks to the media during a news conference in Tel Aviv July 27, 2010. Teva Pharmaceutical Industries, the world's largest generic drugmaker, reported higher quarterly
Teva to pay $523m. to New York as it looks to move past opioid lawsuits - The Jerusalem Post
AstraZeneca Slumps on Report CEO Is Heading to Teva
/cloudfront-us-east-2.images.arcpublishing.com/reuters/MH2PVUNNZRPNDLH3JJFMAIF3GE.jpg "Teva reaches proposed $4.35 bln settlement of U.S. opioid lawsuits | Reuters")
Teva reaches proposed $4.35 bln settlement of U.S. opioid lawsuits | Reuters
San Francisco To Start Opioid Epidemic Trial Against Teva, Walgreen: Reuters
Walgreens, Teva accused of fueling opioid addiction in quest for new markets | Reuters
Teva divesting $1 billion in assets to clear Allergan deal | Reuters.com
Teva Tries to Put an End to the Opioid Wars - WSJ
Israeli Unions Warn Teva Pharm Over Plan to Close Ashdod Plant
Biden admin urges Supreme Court to hear 'skinny labels' case between Teva, GSK | Reuters
Teva and Eli Lilly scrap over migraine drug rights — MedWatch
Teva Pharmaceutical CFO to step down: media | Reuters.com
